High glucose enhances angiotensin-II-mediated peroxisome proliferation-activated receptor-γ inactivation in human coronary artery endothelial cells

Experimental and Molecular Pathology

Volumn 88, Issue 1, 2010, Pages 133-137

  Min, Qing ^a,b   Bai, Yu Ting ^b   Jia, Guanghong ^b   Wu, Jiliang ^b   Xiang, Ji Zhou ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adhesion molecules; Angiotensin II; Atherosclerosis; High glycemia; Peroxisome Proliferation activated receptor ; Vascular endothelial cells

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CELL ADHESION MOLECULE; GLUCOSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TROGLITAZONE;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; CELL ADHESION MOLECULES; CELLS, CULTURED; CHROMANS; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GENE SILENCING; GLUCOSE; HUMANS; PPAR GAMMA; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, SMALL INTERFERING; THIAZOLIDINEDIONES; UP-REGULATION;

EID: 74749101230     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.09.011     Document Type: Article

References (25)

1. Alexis J.D., et al. Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells. Circ. Res. 104 (2009) 69-78
2. Altman R., et al. Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB. Vascul. Pharmacol. 48 (2008) 76-84
3. Arun K.H., et al. High glucose concentration augments angiotensin II mediated contraction via AT1 receptors in rat thoracic aorta. Pharmacol. Res. 50 (2004) 561-568
4. Bokkala S., et al. Effect of angiotensin II and ethanol on the expression of connexin 43 in WB rat liver epithelial cells. Biochem. J. 357 (2001) 769-777
5. Cianchetti S., et al. Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. Atherosclerosis 198 (2008) 22-28
6. Daemen M.J., et al. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ. Res. 68 (1991) 450-456
7. Duan S.Z., et al. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Circ. Res. 102 (2008) 283-294
8. Fernandez A.Z. Peroxisome proliferator-activated receptors in the modulation of the immune/inflammatory response in atherosclerosis. PPAR Res. (2008) 285842 2008
9. Hamilton S.J., et al. Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. Diab. Vasc. Dis. Res. 4 (2007) 89-102
10. Jandeleit-Dahm K.A., et al. Direct antiatherosclerotic effects of PPAR agonists. Curr. Opin. Lipidol. 20 (2009) 24-29
11. Jia G., et al. Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway. J. Mol. Cell Cardiol. 44 (2008) 882-890
12. Lee K.S., et al. PPARdelta activation inhibits angiotensin II induced cardiomyocyte hypertrophy by suppressing intracellular Ca2+ signaling pathway. J. Cell Biochem. 106 (2009) 823-834
13. Li D., et al. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation 102 (2000) 1970-1976
14. Little P.J., et al. Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis. J. Cardiovasc. Pharmacol. 51 (2008) 274-279
15. Marrero M.B., et al. Role of the JAK/STAT signaling pathway in diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 290 (2006) F762-768
16. Meerarani P., et al. Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications. Curr. Mol. Med. 6 (2006) 501-514
17. Ono Y., et al. Telmisartan decreases plasma levels of asymmetrical dimethyl-l-arginine and improves lipid and glucose metabolism and vascular function. Int. Heart J. 50 (2009) 73-83
18. Onozaki A., et al. Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione. Biochem. Biophys. Res. Commun. 317 (2004) 24-29
19. Sasaki M., et al. Troglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alpha. BMC Physiol. 5 (2005) 3
20. Siekmeier R., et al. Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function. J. Cardiovasc. Pharmacol. Ther. 13 (2008) 279-297
21. Sodhi C.P., et al. Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H846-852
22. Trovati M., and Ashwin P. Tangency properties of a pentagonal tiling generated by a piecewise isometry. Chaos 17 (2007) 043129
23. Vaccari C.S., et al. Mechanisms of benefit of angiotensin receptor blockers in coronary atherosclerosis. Am. J. Med. Sci. 336 (2008) 270-277
24. Wang L.H., et al. Statins reduce connexin40 and connexin43 expression in atherosclerotic aorta of rabbits. Int. J. Cardiol. 100 (2005) 467-475
25. Yumuk V.D. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors. Ann. N Y Acad. Sci. 1083 (2006) 306-318